Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(17%)
Results Posted
40%(2 trials)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_2
1
17%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(5)

Detailed Status

Completed5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 41 (20.0%)
N/A3 (60.0%)

Trials by Status

completed583%
recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_4

Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study

NCT06218030
completednot_applicable

Combination Therapy of Different Antidepressants With Dietary Supplements

NCT05931965
completednot_applicable

The Use Of L-Methylfolate As A Treatment For Depression

NCT02133898
completedphase_2

L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults

NCT01853280
completednot_applicable

A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients

NCT01091506
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06218030Phase 4

Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study

Recruiting
NCT05931965Not Applicable

Combination Therapy of Different Antidepressants With Dietary Supplements

Completed
NCT02133898Not Applicable

The Use Of L-Methylfolate As A Treatment For Depression

Completed
NCT01853280Phase 2

L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults

Completed
NCT01091506Not Applicable

A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients

Completed
NCT01001559

Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis

Completed

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6